248 related articles for article (PubMed ID: 16278233)
1. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.
Wang C; Ko HS; Thomas B; Tsang F; Chew KC; Tay SP; Ho MW; Lim TM; Soong TW; Pletnikova O; Troncoso J; Dawson VL; Dawson TM; Lim KL
Hum Mol Genet; 2005 Dec; 14(24):3885-97. PubMed ID: 16278233
[TBL] [Abstract][Full Text] [Related]
2. Formation of parkin aggregates and enhanced PINK1 accumulation during the pathogenesis of Parkinson's disease.
Um JW; Park HJ; Song J; Jeon I; Lee G; Lee PH; Chung KC
Biochem Biophys Res Commun; 2010 Mar; 393(4):824-8. PubMed ID: 20171192
[TBL] [Abstract][Full Text] [Related]
3. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
Ko HS; Lee Y; Shin JH; Karuppagounder SS; Gadad BS; Koleske AJ; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16691-6. PubMed ID: 20823226
[TBL] [Abstract][Full Text] [Related]
5. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival.
Muqit MM; Davidson SM; Payne Smith MD; MacCormac LP; Kahns S; Jensen PH; Wood NW; Latchman DS
Hum Mol Genet; 2004 Jan; 13(1):117-35. PubMed ID: 14645198
[TBL] [Abstract][Full Text] [Related]
6. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.
Chung KK; Thomas B; Li X; Pletnikova O; Troncoso JC; Marsh L; Dawson VL; Dawson TM
Science; 2004 May; 304(5675):1328-31. PubMed ID: 15105460
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations.
Wang C; Tan JM; Ho MW; Zaiden N; Wong SH; Chew CL; Eng PW; Lim TM; Dawson TM; Lim KL
J Neurochem; 2005 Apr; 93(2):422-31. PubMed ID: 15816865
[TBL] [Abstract][Full Text] [Related]
8. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
9. Parkin and defective ubiquitination in Parkinson's disease.
Dawson TM
J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
[TBL] [Abstract][Full Text] [Related]
10. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
[TBL] [Abstract][Full Text] [Related]
11. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
Jiang H; Ren Y; Zhao J; Feng J
Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
[TBL] [Abstract][Full Text] [Related]
12. Parkin: much more than a simple ubiquitin ligase.
Alves da Costa C; Checler F
Neurodegener Dis; 2012; 10(1-4):49-51. PubMed ID: 22204976
[TBL] [Abstract][Full Text] [Related]
13. New insights into Parkinson's disease.
Chung KK; Dawson VL; Dawson TM
J Neurol; 2003 Oct; 250 Suppl 3():III15-24. PubMed ID: 14579120
[TBL] [Abstract][Full Text] [Related]
14. Dopamine covalently modifies and functionally inactivates parkin.
LaVoie MJ; Ostaszewski BL; Weihofen A; Schlossmacher MG; Selkoe DJ
Nat Med; 2005 Nov; 11(11):1214-21. PubMed ID: 16227987
[TBL] [Abstract][Full Text] [Related]
15. Genetics of parkin-linked disease.
West AB; Maidment NT
Hum Genet; 2004 Mar; 114(4):327-36. PubMed ID: 14727181
[TBL] [Abstract][Full Text] [Related]
16. Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's disease.
Song P; Li S; Wu H; Gao R; Rao G; Wang D; Chen Z; Ma B; Wang H; Sui N; Deng H; Zhang Z; Tang T; Tan Z; Han Z; Lu T; Zhu Y; Chen Q
Protein Cell; 2016 Feb; 7(2):114-29. PubMed ID: 26746706
[TBL] [Abstract][Full Text] [Related]
17. Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells.
Koch A; Lehmann-Horn K; Dächsel JC; Gasser T; Kahle PJ; Lücking CB
Parkinsonism Relat Disord; 2009 Mar; 15(3):220-5. PubMed ID: 18586549
[TBL] [Abstract][Full Text] [Related]
18. NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease.
Korutla L; Furlong HA; Mackler SA
Neuroscience; 2014 Jan; 257():86-95. PubMed ID: 24231739
[TBL] [Abstract][Full Text] [Related]
19. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
[TBL] [Abstract][Full Text] [Related]
20. Parkin-associated Parkinson's disease.
von Coelln R; Dawson VL; Dawson TM
Cell Tissue Res; 2004 Oct; 318(1):175-84. PubMed ID: 15503153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
